Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lyell Immunopharma, Inc. | Director | Option (right to buy) | 260K | Oct 31, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LYEL | Lyell Immunopharma, Inc. | Oct 31, 2024 | 1 | $0 | 4 | Nov 1, 2024 | Director |
LYEL | Lyell Immunopharma, Inc. | Oct 31, 2024 | 0 | $0 | 3 | Nov 1, 2024 | Director |